By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Immunovaccine Inc. 

1819 Granville Street
Suite 303
Halifax  Nova Scotia  B3J 3R1  Canada
Phone: 902-492-1819 Fax: 902-492-0888




Company News
Ebola Epidemic Unlikely But Not Impossible, Says Immunovaccine Inc. CEO 10/29/2014 8:02:06 AM
Immunovaccine Inc. Demonstrates Protection Against Lethal Anthrax Challenge With Rapid Acting, Single Dose Vaccine 10/21/2014 2:17:54 PM
Immunovaccine Inc. To Provide Update On Ongoing Ebola Virus And Cancer Vaccine Programs At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/20/2014 2:59:00 PM
Ebola Vaccine Using Immunovaccine Inc.’s DepoVax Proves Highly Efficacious In Non-Human Primate Study 10/20/2014 1:25:46 PM
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/20/2014 3:28:01 AM
Immunovaccine Inc. Reports Positive Results From Two Anthrax Studies 9/9/2013 7:45:45 AM
Immunovaccine Inc. Files for Name and Symbol Change; After Necessary Approvals, Company Will be Called: Tauriga Sciences, Inc. 3/4/2013 9:42:22 AM
Immunovaccine Inc. Investor Presentation Now Available for on-Demand Viewing at 10/8/2012 10:49:44 AM
Immunovaccine Inc. to Webcast, Live, at on October 4th 10/4/2012 12:21:55 PM
Immunovaccine Inc. Announces Appointment of John Trizzino as CEO 9/12/2011 7:09:10 AM